Flinton Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Flinton Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$13.6M	Buy	267,960 +83,272	+45%	+$3.91M	0.42%	47
2019 Q2	$8.38M	Buy	184,688 +138,936	+304%	+$6.47M	0.26%	77
2019 Q1	$2.18M	Buy	45,752 +18,928	+71%	+$943K	0.07%	203
2018 Q4	$1.39M	Sell	26,824 -3,752	-12%	-$202K	0.05%	237
2018 Q3	$1.9M	Sell	30,576 -476	-2%	-$28.2K	0.06%	224
2018 Q2	$1.72M	Sell	31,052 -5,964	-16%	-$322K	0.06%	236
2018 Q1	$2.34M	Buy	37,016 +5,964	+19%	+$384K	0.08%	192
2017 Q4	$1.9M	Buy	31,052 +14,476	+87%	+$905K	0.06%	210
2017 Q3	$1.06M	Buy	+16,576	New	+$968K	0.04%	265
2017 Q1	–	Sell	-17,808	Closed	-$1.04M	–	849
2016 Q4	$1.04M	Buy	+17,808	New	+$974K	0.05%	237

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Flinton Capital Management's BMY Position: Q3 2019 in Review

Flinton Capital Management increased its Bristol-Myers Squibb (BMY) stake by 45% in Q3 2019, buying an estimated $3.91M and bringing the position to 267,960 shares worth $13.6M. The position accounts for 0.42% of the portfolio, ranked #47.

Flinton Capital Management first reported a position in BMY in Q4 2016 and has held it in 10 quarters since. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Flinton Capital Management held 267,960 shares of Bristol-Myers Squibb worth $13.6M as of Q3 2019.
Flinton Capital Management bought 83,272 Bristol-Myers Squibb shares in Q3 2019, an estimated $3.91M.
Bristol-Myers Squibb made up 0.42% of Flinton Capital Management's portfolio in Q3 2019, its #47 holding.
Flinton Capital Management first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 10 quarters since.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.